戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 TAC, in addition to the previously described P2X1 receptor.
2  can promote platelet activation through the P2X1 receptor.
3 cessibility of cysteine mutants at the human P2X1 receptor.
4 SP90 inhibitors consistent with an effect on P2X1 receptors.
5  effect on both recombinant and native human P2X1 receptors.
6  nerves, causes vasoconstriction largely via P2X1 receptors.
7 was reduced 50% by GsMTx-4, independently of P2X1 receptors.
8 striction through ATP-mediated activation of P2X1 receptors.
9 ist, through its effects on P2Y1, P2Y12, and P2X1 receptors.
10 onding 5-methylphosphonate was equipotent at P2X1 receptors.
11  much less sensitive to TNP-ATP than was the P2X(1) receptor.
12 noreactivity for both P2X2 and P2X3, but not P2X1, receptors.
13 id the profound desensitization exhibited by P2X(1) receptors.
14  in the binding of both suramin and NF449 to P2X(1) receptors.
15 , suggesting a common origin: ATP binding to P2X(1) receptors.
16            In cells expressing the homomeric P2X1 receptor, 30 microM alpha,beta-methylene ATP (alpha
17   These receptors co-exist with ligand-gated P2X1 receptors activated by ATP analogs and high levels
18 Ca(2+) response was predominantly because of P2X1 receptors activated by ATP release via a phospholip
19 that ATP-induced vasodilation is mediated by P2X(1) receptor activation on mesenteric arterial endoth
20 dase activity was required to fully preserve P2X1 receptor activation by ATP in vitro.
21 s study reveals a novel inhibitory effect of P2X1 receptor activation on subsequent increases in musc
22                   In the ex vivo retina, the P2X1 receptor agonist alpha,beta-methylene ATP (300 nm)
23 and alpha, beta-methylene-ATP (40 microM), a P2X1 receptor agonist, had no effect on ADP-induced plat
24                                              P2X(1) receptors also participate in platelet shape chan
25                                              P2X1 receptors also enhanced Ca(2+) responses when costi
26                                  ATP acts on P2X1 receptors, although contributions from other P2X an
27       We conclude that Ca(2+) influx through P2X1 receptors amplifies Ca(2+) signaling through P2Y1 a
28         It has previously been reported that P2X1 receptors amplify P2Y1-evoked Ca(2+) responses in p
29                     We looked at whether the P2X1 receptor, an ATP-gated cation channel present on pl
30 cal studies have indicated expression of the P2X1 receptor, an ATP-gated cation channel, in human and
31 X receptor that has the properties of cloned P2X1 receptors and is similar to native receptors in smo
32                              The presence of P2X1 receptors and vanilloid receptor like 1 protein on
33 splayed an IC50 value of 9 nM at recombinant P2X1 receptors and was 1300-, 16-, and > 10,000-fold sel
34 er potency and efficacy of BzATP and Ap5A at P2X1 receptors) and antagonists.
35 selective antagonists in regulating platelet P2X1 receptors, and their potential effects on hemostasi
36 monstrate that HIV-1 infection is reduced by P2X1 receptor antagonism.
37 aneous depolarizations were abolished by the P2X(1) receptor antagonist NF449 (10 microm) (frequency
38                               The purinergic P2X1 receptor antagonist NF449, the purinergic P2X7 rece
39 hat inhibition of HIV-1 fusion by a specific P2X1 receptor antagonist, NF279, is due to the blocking
40                                              P2X1 receptor antagonists could thus represent a new cla
41                                        Thus, P2X1 receptor antagonists inhibit, but do not abolish, t
42 nd suggest that the development of selective P2X1 receptor antagonists may provide an effective non-h
43 ent the first potent, non-acidic, allosteric P2X1 receptor antagonists reported to date.
44                                      We used P2X1 receptor antagonists to further characterize the pu
45 tent inhibition of HIV-1 fusion by selective P2X1 receptor antagonists, including NF279, and suggeste
46 , we characterize the inhibitory activity of P2X1 receptor antagonists, NF279 and NF449, in cell line
47                    Knockout mice lacking the P2X(1) receptor appear normal, but fail to breed.
48 ithin the second transmembrane domain of the P2X1 receptor appeared to confer on the receptor the ina
49                                              P2X1 receptors are adenosine triphosphate (ATP)-gated ca
50                      These results show that P2X1 receptors are essential for normal male reproductiv
51                         P1, P2Y1, P2Y12, and P2X1 receptors are expressed on platelets, which mediate
52 /mobilization demonstrated that the platelet P2X1 receptors are pharmacologically distinct from the w
53         Although these findings suggest that P2X1 receptors are present in both blood leukocytes and
54  membranes with endoglycosidase-F causes the P2X1 receptor band to migrate as a 46-kD protein, verify
55                                              P2X(1) receptors belong to a family of cation channels g
56 danamycin almost abolished this movement for P2X1 receptors but had no effect on P2X2 receptor traffi
57                                     Platelet P2X1 receptor-, but not P2Y1 receptor-, mediated increas
58 toma cells stably transfected with the human P2X1 receptor by measuring inhibition of the ATP-induced
59 This study demonstrates that in neurons, the P2X1 receptor can contribute to the properties of hetero
60 he carboxyl terminus that slowed recovery of P2X1 receptor currents (7-fold less recovery at 30 secon
61                                              P2X1 receptor currents in HEK293 cells were reduced by a
62                                              P2X1 receptor deficiency also was associated with a mark
63 B neurones, but were absent in the MNTB from P2X(1) receptor-deficient mice demonstrating a functiona
64 a,beta-meATP) sensitive, and in neurons from P2X1 receptor-deficient mice the alpha,beta-meATP respon
65                                           In P2X1-receptor-deficient mice, contraction of the vas def
66       NF023 (50 mum), a potent antagonist of P2X1 receptors, dilated retinal arterioles by 32.1 +/- 2
67 tions in the extracellular loop of the human P2X1 receptor during not only agonist binding and desens
68  and blood platelets, the relative levels of P2X1 receptor expression and function in human blood leu
69                                 By contrast, P2X1 receptor expression is strongly maintained during m
70  platelets, we show that maximally activated P2X1 receptors failed to stimulate significant aggregati
71 latively selective pharmacological probes of P2X1 receptors, filling a long-standing need in the P2 r
72                                              P2X1 receptors for ATP are ligand-gated cation channels,
73 single mutation of residue 23 also protected P2X1 receptors from inhibition by EPAC activation.
74 trical field stimulation, suggesting altered P2X1 receptor function with a propensity to desensitize.
75 that NTPDase1 is required to maintain normal P2X1 receptor functionality in the vas deferens and that
76  receptors, suggesting the downregulation of P2X1 receptor gene expression during the differentiation
77  90% in mice with a targeted deletion of the P2X1 receptor gene.
78           Neither the P2TAC receptor nor the P2X1 receptor has any significant role in this response.
79 nother cAMP effector; however, its effect on P2X1 receptors has not yet been determined.
80                      Mapping these data to a P2X1 receptor homology model identifies significant conf
81 nd characterized genomic clones of the human P2X1 receptor (hP2X1) gene in an effort to understand it
82 The potency of compound 3 at the recombinant P2X1 receptor (IC50 10.2 +/- 2.6 microM) was lower than
83 e observations establish a critical role for P2X(1) receptors in the ATP vasodilator pathway.
84 ent mice demonstrating a functional role for P2X(1) receptors in the CNS.
85      This study reveals a major role for the P2X1 receptor in LPS-induced lethal endotoxemia through
86 h-resolution cryo-EM structures of the human P2X1 receptor in the apo closed, ATP-bound desensitized,
87                      Given the expression of P2X1 receptors in a range of neurons, it seems likely th
88 rted by the lack of detectable expression of P2X1 receptors in cells used in fusion experiments and b
89 port that there is significant expression of P2X1 receptors in human platelets, but not in neutrophil
90                                  Deletion of P2X1 receptors in KO mice significantly blunted autoregu
91  Emerging literature suggests a key role for P2X1 receptors in mediating this chronic inflammation, b
92 tions about the previously suggested role of P2X1 receptors in thymocyte apoptosis.
93                          Incubation with the P2X(1) receptor inhibitor NF023 did not alter ATP-stimul
94 colocalized with somatostatin and purinergic P2X1 receptor-IR but not with tyrosine hydroxylase-IR.
95 periments conducted in this study imply that P2X1 receptor is not expressed in target cells or involv
96 icates that Schiff's base formation with the P2X1 receptor is not necessarily required for recognitio
97                              The activity of P2X1 receptors is modulated by lipids and intracellular
98 ributed to the influx of cations through the P2X(1) receptor - is of larger amplitude for sAPs (2248
99 fine the molecular pharmacology of the human P2X1 receptor laying the foundation for structure-based
100 agents that potentiate the actions of ATP at P2X1 receptors may be useful in the treatment of male in
101                                              P2X1 receptors may therefore require interaction with an
102         This study tests the hypothesis that P2X1 receptors mediate pressure-induced afferent arterio
103 immunoblot analysis and functional assays of P2X1 receptor-mediated ionic fluxes, we report that ther
104           Geldanamycin also inhibited native P2X1 receptor-mediated responses.
105 unoblot analysis indicated that the platelet P2X1 receptor migrates as an approximately 60-kD protein
106 sulted in the up-regulation of P2Y2, but not P2X1, receptor mRNA.
107                               Mutagenesis on P2X(1) receptors of conserved residues in mammalian P2X
108 mice, we demonstrate that the absence of the P2X1 receptor on neutrophils was responsible for this de
109                                    Homomeric P2X1 receptors open on binding ATP and then transition t
110 ps from wild type mice and mice deficient in P2X1 receptors (P2X1(-/-)) before and after pharmacologi
111                                  For VCF the P2X1 receptor (P2X1R) K190C mutant (adjacent to the agon
112                                     Platelet P2X1 receptors play an important role in hemostasis, con
113  production, ATP release, and stimulation of P2X1 receptors represent a standby purinergic signaling
114                           Sensitivity to the P2X1 receptor-selective antagonist NF449 was reduced by
115              Electron microscopy of purified P2X1 receptors showed marked changes in structure on ATP
116                Although it is known that the P2X1 receptor subtype has increased sensitivity to ATP a
117 2X receptors with a phenotype resembling the P2X1 receptor subtype on cerebral resistance arterioles.
118 = 19) were detectably immunoreactive for the P2X1 receptor subunit.
119  express functionally significant numbers of P2X1 receptors, suggesting the downregulation of P2X1 re
120 tant Ca(2+) mobilization pathways, including P2X1 receptors, that may be particularly important durin
121 out affecting the percentage contribution of P2X1 receptors to collagen-evoked Ca(2+) responses, indi
122 n leads to rapid engagement of smooth muscle P2X1 receptors to increase action potentials (Ca(2+) fla
123  occur when sufficient cation influx through P2X(1) receptors triggers L-type Ca(2+) channels; the fi
124  expression for the ligand-gated ion channel P2X1 receptor was detected in rat, but not mouse, thymoc
125                              Human and mouse P2X(1) receptors were expressed in human embryonic kidne
126 e cation channels from the rat vas deferens (P2X1 receptors) were stably expressed in HEK 293 cells,
127 tracellular ligand-binding loop of the human P2X1 receptor, which is inhibited by NF449, suramin, and
128 Healthy human eosinophils express functional P2X1 receptors whose activation leads to eosinophil alph
129 e potentiator of ATP-evoked responses at rat P2X1 receptors with an EC50 value of 5.9 +/- 1.8 microM,
130                                  Blockade of P2X1 receptors with NF279 blocked pressure-mediated vaso

 
Page Top